BSE •
Medicamen Biotech's board will meet on Feb 13, 2026, to review unaudited financial results for Q3 and nine months ending Dec 31, 2025.
Trading window remains closed till Feb 15, 2026, for designated persons and their immediate relatives, as per insider trading norms.